Models of Physiology and Physiologically Based Models in Clinical Pharmacology

被引:9
|
作者
Atkinson, A. J., Jr. [1 ]
Smith, B. P. [2 ]
机构
[1] Northwestern Univ, Dept Mol Pharmacol & Biochem, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Amgen Inc, Biostat Med Sci, Thousand Oaks, CA USA
关键词
KINETICS; CIRCULATION; PHARMACOKINETICS; HETEROGENEITY; AGENTS; BLOOD; FLOW;
D O I
10.1038/clpt.2012.67
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
As science matures, it becomes more mathematical, progressing from enumeration to the use of equations to the formulation of models. Clinical pharmacology has developed to the stage where models play an increasingly important role in predicting and analyzing drug pharmacokinetics and pharmacodynamics, and even in characterizing disease progression and therapeutic response. Useful models have two characteristics that are in ostensible conflict: (i) they must accurately represent the essential features of the underlying system and (ii) the representation must be sufficiently simplified to enable its salient features to be identified and investigated through further experimentation.
引用
收藏
页码:3 / 6
页数:4
相关论文
共 50 条
  • [31] Physiologically based pharmacokinetic models of 2',3'-dideoxyinosine
    Kang, HJK
    Wientjes, MG
    Au, JLS
    PHARMACEUTICAL RESEARCH, 1997, 14 (03) : 337 - 344
  • [32] Physiologically based pharmacokinetic models for everolimus and sorafenib in mice
    Dipti K. Pawaskar
    Robert M. Straubinger
    Gerald J. Fetterly
    Bonnie H. Hylander
    Elizabeth A. Repasky
    Wen W. Ma
    William J. Jusko
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1219 - 1229
  • [33] Bayesian analysis of physiologically based toxicokinetic and toxicodynamic models
    Hack, CE
    TOXICOLOGY, 2006, 221 (2-3) : 241 - 248
  • [34] INHALATION ANESTHESIA USING PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELS
    FISEROVABERGEROVA, V
    DRUG METABOLISM REVIEWS, 1992, 24 (04) : 531 - 557
  • [35] The Link Between Pharmacodynamics and Physiologically Based Pharmacokinetic Models
    Perera, V.
    Elmeliegy, M. A.
    Rao, G.
    Forrest, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (02) : 151 - 152
  • [36] Have physiologically-based pharmacokinetic models delivered?
    Edginton, Andrea N.
    Joshi, Ghanashyam
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2011, 7 (08) : 929 - 934
  • [37] Applications of minimal physiologically-based pharmacokinetic models
    Yanguang Cao
    William J. Jusko
    Journal of Pharmacokinetics and Pharmacodynamics, 2012, 39 : 711 - 723
  • [38] Physiologically based pharmacokinetic models for everolimus and sorafenib in mice
    Pawaskar, Dipti K.
    Straubinger, Robert M.
    Fetterly, Gerald J.
    Hylander, Bonnie H.
    Repasky, Elizabeth A.
    Ma, Wen W.
    Jusko, William J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) : 1219 - 1229
  • [39] Applications of minimal physiologically-based pharmacokinetic models
    Cao, Yanguang
    Jusko, William J.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2012, 39 (06) : 711 - 723
  • [40] Examination of Physiologically-Based Pharmacokinetic Models of Rosuvastatin
    Bowman, Christine M.
    Ma, Fang
    Mao, Jialin
    Chen, Yuan
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (01): : 5 - 17